Memantine (a N-Methyl-d-Aspartate Receptor Antagonist) in the Treatment of Neuropathic Pain After Amputation or Surgery: A Randomized, Double-Blinded, Cross-Over Study-Reference-Cited by-同舟云学术

Memantine (a N-Methyl-d-Aspartate Receptor Antagonist) in the Treatment of Neuropathic Pain After Amputation or Surgery: A Randomized, Double-Blinded, Cross-Over Study

Published:2000-10 Issue:4 Volume:91 Page:960-966
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:Anesthesia & Analgesia

Author:

Nikolajsen Lone,Gottrup Hanne,Kristensen Anders G. D.,Jensen Troels S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference23 articles.

1. The influence of preamputation pain on postamputation stump and phantom pain

2. Immediate and long-term phantom limb pain in amputees: Incidence, clinical characteristics and relationship to pre-amputation limb pain

3. Effect of i.v. ketamine in combination with epidural bupivacaine or epidural morphine on postoperative pain and wound tenderness after renal surgery

4. The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

5. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to neuropathic amputation-related pain: narrative review of surgical, interventional, and medical treatments;Regional Anesthesia & Pain Medicine;2024-02-02

2. Pain management in the postoperative period of amputation surgeries: A scoping review;Journal of Clinical Nursing;2023-08-21

3. Management of diabetic neuropathy with memantine: A randomized clinical trial;Diabetes and Vascular Disease Research;2023-07

4. NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain;Frontiers in Cellular Neuroscience;2022-09-27

5. Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study;BMC Neurology;2022-05-13